These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30907290)

  • 1. Actors in whitespace: Communicating risk information on pharmaceutical websites.
    O'Donoghue AC; Sullivan HW; Rupert DJ; Fitts Willoughby J; Aikin KJ
    Health Mark Q; 2019; 36(2):152-167. PubMed ID: 30907290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites.
    Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Aikin KJ
    J Health Commun; 2017 Feb; 22(2):171-181. PubMed ID: 28129069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.
    Sullivan HW; O'Donoghue AC; Gard Read J; Amoozegar JB; Aikin KJ; Rupert DJ
    J Med Internet Res; 2018 Jan; 20(1):e13. PubMed ID: 29362205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumer confusion between prescription drug precautions and side effects.
    Amoozegar JB; Rupert DJ; Sullivan HW; O'Donoghue AC
    Patient Educ Couns; 2017 Jun; 100(6):1111-1119. PubMed ID: 28069321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Information on Oncology Prescription Drug Websites.
    Sullivan HW; Aikin KJ; Squiers LB
    J Cancer Educ; 2018 Apr; 33(2):371-374. PubMed ID: 27589969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising.
    Jiang P
    Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
    Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
    [No Abstract]   [Full Text] [Related]  

  • 9. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.
    Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG
    Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
    Aikin KJ; Sullivan HW; Betts KR
    J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of risk disclosure prominence in direct-to-consumer advertising (DTCA) of prescription drugs: An integrative cognitive process model.
    Ju I; Park JS
    Health Mark Q; 2018; 35(1):32-46. PubMed ID: 29608136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disclosing accelerated approval on direct-to-consumer prescription drug websites.
    Sullivan HW; O'Donoghue AC; David KT; Patel NJ
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1277-1280. PubMed ID: 30264874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.
    Sullivan HW; O'Donoghue AC; Rupert DJ; Willoughby JF; Amoozegar JB; Aikin KJ
    J Health Commun; 2016 Nov; 21(11):1198-1207. PubMed ID: 27805473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
    Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
    Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of imagination in consumers' processing of visual metaphors in prescription drug advertising.
    Foreman JR; Hsieh MH; Grover A
    Health Mark Q; 2019; 36(3):169-185. PubMed ID: 31180277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising.
    Aikin KJ; Boudewyns V; Betts KR; Southwell BG; Williams P
    J Health Commun; 2019; 24(5):536-546. PubMed ID: 31253071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach.
    Bhutada NS; Rollins BL; Perri M
    Health Commun; 2017 Apr; 32(4):391-400. PubMed ID: 27315337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the educational value of direct-to-consumer advertising of prescription drugs.
    Hwang MJ; Young HN
    J Am Pharm Assoc (2003); 2017; 57(5):571-578. PubMed ID: 28676435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
    O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.